W
Waymark
Enables community based care, using technology, to catalyze improvements in access and outcomes for patients receiving Medicaid benefits
About Waymark
Waymark Care is a health-tech startup that operates in the healthcare sector, specifically focusing on providing comprehensive care services to patients enrolled in Medicaid programs. The company's primary mission is to improve access to quality healthcare by connecting patients with a local care team composed of community health workers, therapists, pharmacists, and care coordinators.
Read full description
The business model of Waymark Care is centered around a community-based approach to healthcare. The company's care teams live and work in the same communities as their patients, allowing for personalized and convenient care. These teams assist patients in navigating the often complex healthcare system, coordinating medical appointments, managing prescription refills, and helping find assistance with essential needs such as food, housing, and transportation.
Waymark Care makes its money through partnerships with health plans and primary care providers. These partnerships allow Waymark Care to offer its services at no cost to the patients, thereby improving access to quality healthcare for those who need it most.
The company's commitment to patient-centered care is reflected in its decision to become a public benefit corporation. This means that while Waymark Care is a for-profit company, it is legally obligated to consider the impact of its decisions on its patients, the community, and the public as a whole.
In summary, Waymark Care is a health-tech startup that aims to improve access to quality healthcare for Medicaid patients by providing comprehensive, community-based care services.
Latest news
Press, funding announcements and product moves mentioning Waymark.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBTDebt | Oct 2023 | $20M | — | Undisclosed | ↗ |
| EARLY VCOther financing | Oct 2023 | $22M | $225M | Andreessen Horowitz · Lux Capital · NEA · CVS Health Ventures | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Waymark is 11K monthly website visits, up 29.4% over the last three months. Waymark's team grew 2.4% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Andreessen Horowitz
NEA
Ensemblelabs
Lux Capital
CVS Health Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Waymark on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Waymark’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






